Systemic lupus erythematosus associated with primary large cell carcinoma of the lung

Medical Oncology

Volumn 15, Issue 4, 1998, Pages 289-291

  Irie, Hidemi ^a   Satoh, Hiroaki ^a   Akama, Takao ^a   Yamashita, Yuko T ^a   Ishikawa, Hiroichi ^a   Ohtsuka, Morio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Lung cancer; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; BLEEDING; CANCER RECURRENCE; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; INFERIOR CAVA VEIN; LARGE CELL CARCINOMA; LUNG CARCINOMA; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032456327     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02787216     Document Type: Article

References (15)

1. Sela O, Shoenfeld Y. Cancer in autoimmune diseases. Semin Arthritis Rheum 1998; 18: 78-87.
2. Cash JM, Klippel JH. Rheumatic diseases and cancer. Clin Exp Rheumatol 1991; 9: 109-112.
3. Black KA, Zilko PJ, Dawkins RL, Armstrong BK, Mastaglia GL. Cancer in connective disease. Arthritis Rheum 1982; 25: 1130-1133.
4. Talal N, Bujim JJ. Development of malignant lymphoma in the course of Sjögren's syndrome. Am J Med 1964; 36: 529-540.
5. Shimokawara I, Imamura M, Yamanaka N, Ishii Y, Kikuchi K. Identification of lymphocyte subpopulation in human breast cancer tissue and its significance. Cancer 1982; 49: 1456-1464.
6. Kigawa J, Kanamori Y, Takeuchi Y, Minagawa Y, Terakawa N. Involvement of the local immune response in a case of advanced cervical cancer in a patient with systemic lupus erythematosus. Gynecol Obstet Invest 1993; 36: 62-64.
7. + cells: the Ly-1 B lineage. Ann Rev Immunol 1988; 6: 194-218.
8. Bataille R, Klein B, Durie BGM. The relationship between autoimmune states and B cell proliferations. J Rheumatol 1989; 16: 1023-1024.
9. Pettersson T, Pukkala E, Teppo L, Friman C. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rhem Dis 1992; 51: 437-439.
10. Nyberg G, Eriksson O, Westberg NG. Increased incidence of cervical atypia in women with lupus erythematosus treated with chemotherapy. Arthritis Rheum 1981; 24: 648-650.
11. Sulkes A, Naparstek YN. The infrequent association of systemic lupus erythematosus and solid tumors. Cancer 1991; 68: 1389-1393.
12. Canoso JJ, Cohen AS. Malignancy in a series of 70 patients with systemic lupus erythematosus. Arthritis Rheum 1974; 17: 383-390.
13. Lewis RB, Castor CW, Knisley R, Bole GG. Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1976; 19: 1256-1260.
14. Mellemkjaer L et al. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 761-768.
15. Schur PH. Clinical features of SLE. In: WN Kelley, ED Harris Jr, S Ruddy, CB Sledge (eds). Textbook of Rheumatology. Saunders: Philadelphia, 1993.